Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 7 (4), 169-174

Prevalence of Metabolic Syndrome in Pre- And Post-Menopausal Women: A Prospective Study From Apex Institute of North India

Affiliations

Prevalence of Metabolic Syndrome in Pre- And Post-Menopausal Women: A Prospective Study From Apex Institute of North India

Sandeep Sharma et al. J Midlife Health.

Abstract

Background: The metabolic syndrome (MS) (syndrome X, insulin resistance syndrome) is a constellation of metabolic abnormalities and a complex predisease state that predicts future development of type 2 diabetes mellitus and cardiovascular disease. Menopausal transition and postmenopausal state are considered as a vulnerable period for developing MS, and this increased risk has been attributed to decreasing estrogen levels with an increasing risk of insulin resistance following menopause.

Aims and objectives: This study aimed to determine the prevalence of MS and its components in pre- and post-menopausal women from North India.

Methodology: This is a cross-sectional study of 350 women in the age group of 45-55 years attending gynecology clinic in a tertiary center of North India. Details of sociodemographic data, menopausal history, reproductive, and medical profile were obtained. Then, waist circumference, body mass index (BMI), and blood pressure were recorded. A venous blood sample was collected for fasting blood glucose, triglycerides, total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol. MS was defined according to the modified National Cholesterol Education Program Adult Treatment Panel III criteria.

Results: The mean age was 49.09 ± 2.2 years in premenopausal and 49.54 ± 2.8 years in postmenopausal women. The prevalence of MS in the study group was 62.6%. Occurrence of MS was higher in older and obese women. Abnormal waist circumference was the most prevalent component (87%) of MS and in terms of odd ratio, correlation was highest for BMI followed by total cholesterol and waist-hip ratio.

Conclusion: We should target obesity and deranged lipid profile by bringing out changes in lifestyle and dietary habits to decrease the higher prevalence of MS and the risk of cardiovascular diseases.

Keywords: Menopause; metabolic syndrome; postmenopausal women; premenopausal women.

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
The prevalence of individual variables of metabolic syndrome in both groups
Figure 2
Figure 2
Correlation of other components with metabolic syndrome

Similar articles

See all similar articles

Cited by 4 PubMed Central articles

References

    1. Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J. Harrison's Principles of Internal Medicine. 18th ed. New York: The McGraw-Hill Companies; 2012.
    1. de Ferranti SD. Recovery from metabolic syndrome is both possible and beneficial. Clin Chem. 2010;56:1053–5. - PubMed
    1. Shah D. The annual conference of the British menopause society – June 2010. J Midlife Health. 2010;1:48–50. - PMC - PubMed
    1. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: Prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004;33:351–75. - PubMed
    1. Rajewska J, Rybakowski JK. Depression in premenopausal women: Gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:705–9. - PubMed
Feedback